Suppliers and packagers for DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Baxter Hlthcare	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	018037	NDA	Baxter Healthcare Company	0338-0663-04	1000 mL in 1 BAG (0338-0663-04)	1979-02-02

Suppliers and packagers for DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)

Last updated: May 2, 2026

Who Supplies Dextrose 5%, Sodium Chloride 0.2%, and Potassium Chloride 20 mEq (K) IV Infusions?

What product is being specified?

The request maps to an IV solution commonly labeled as a combined dextrose-saline-potassium infusion with the following nominal strengths:

• Dextrose 5% (w/v)
• Sodium chloride 0.2% (w/v)
• Potassium chloride 20 mEq/L (K) (often written as “K 20 mEq” or similar in pharmacy order sets)

These products are typically supplied as sterile, parenteral-grade admixtures via:

• Commercial sterile manufacturers (where an equivalent packaged product exists), or
• Hospital/3PL compounding networks (most common when the exact triple-strength combination is not widely packaged in identical form).

Which supplier categories can meet this exact composition?

Because “Dextrose 5% + Sodium Chloride 0.2% + Potassium Chloride 20 mEq (K)” is frequently handled as a pharmacy-compounded admixture (rather than a standard off-the-shelf “premix” in every market), supplier identification depends on sourcing channel. The categories below reflect how these exact combinations are supplied in practice.

1) Hospitals and health systems (in-house compounding)

Most health systems prepare these as IV admixtures using:

• commercially supplied dextrose 5% IV base
• sodium chloride solution (to achieve 0.2% final)
• potassium chloride injection (to achieve 20 mEq final)

Typical internal supplier inputs come from branded/authorized manufacturers of:

• dextrose injection
• sodium chloride injection
• potassium chloride injection

2) Outsourced sterile compounding providers (3PL/USP <797> compliance)

These suppliers take a prescription order and compound to the ordered strengths under sterile compounding standards. Common infrastructure includes:

• centralized compounding pharmacies
• specialty pharmacy sterile services
• logistics providers distributing to hospitals or care sites

3) Contract sterile manufacturers (if a packaged equivalent exists)

If an equivalent premixed product is commercially packaged in a specific country, the supplier is the manufacturer of that premix. However, exact matching of 0.2% sodium chloride with 20 mEq potassium alongside 5% dextrose is not consistently standardized across all geographies, so packaged availability is less universal than compounded supply.

Supplier list (actionable): common supply sources by component

Instead of naming a single “one supplier” for the final triple-combination (which is often compounded), the reliable procurement route is to source the inputs and/or the sterile compounding service that can combine them to the ordered final concentrations.

A) Dextrose 5% IV (component supply)

Common supplier types for dextrose 5% injection include:

• global injectables manufacturers
• national pharmaceutical generics divisions
• sterile bulk liquid suppliers (for medical channel packaging)

B) Sodium chloride 0.2% IV (component supply)

Most supply channels provide sodium chloride injection at other strengths (commonly 0.9%); the 0.2% final is frequently achieved through dilution during compounding rather than purchasing a dedicated packaged 0.2% bag.

C) Potassium chloride 20 mEq (K) (component supply)

Potassium chloride injection (for example, concentrated KCl injection) is widely available. The 20 mEq final is set by dose during compounding.

How purchasing typically works for this exact order

A buying decision typically resolves to one of two procurement paths:

Procurement path	What you buy	Who supplies it	What matches the 5%/0.2%/20 mEq spec
Compounded IV admixture	Final triple solution	Sterile compounding provider (hospital or outsourced 3PL)	The compounding pharmacy ensures final concentrations
Kit-like inputs	Dextrose + NaCl + KCl injections	Component manufacturers plus compounding site	The compounding pharmacy performs the final mixing

Compliance and packaging constraints buyers usually require

For decision-grade procurement, buyers generally require that the supplier (or compounding site) can meet:

• sterility assurance for compounded IV admixtures
• USP <797> sterile compounding compliance (US)
• labeling accuracy: final concentrations and potassium units in mEq
• traceability to batch/lot numbers for dextrose, sodium chloride, and potassium chloride inputs

Key Takeaways

• The triple-strength order Dextrose 5% + Sodium Chloride 0.2% + Potassium Chloride 20 mEq (K) is most commonly supplied through sterile compounding (hospital or outsourced sterile services), using commercially available dextrose 5%, sodium chloride injection (often diluted to 0.2%), and potassium chloride injection (dosed to 20 mEq).
• Supplier identification in practice is split between (1) sterile compounding providers that deliver the final admixture to specification and (2) component manufacturers supplying the inputs.
• The procurement action that most reliably matches the exact spec is selecting a sterile compounding supplier with documented capability for final-concentration labeling and USP <797> compliant sterile processing.

---

FAQs

1) Is this usually a premixed commercial IV product?

In many markets it is not consistently available as an identical premixed commercial bag, so it is commonly prepared as a compounded admixture to the exact final concentrations.

2) Who is the “supplier” in procurement terms for this order?

Most buyers treat the sterile compounding provider (hospital pharmacy or outsourced sterile 3PL) as the supplier because it delivers the final compounded bag matching 5% dextrose, 0.2% sodium chloride, and 20 mEq potassium.

3) Can sodium chloride 0.2% come from a standard product?

Often the compounding site achieves 0.2% final sodium chloride by diluting sodium chloride injection to the ordered final concentration during admixture preparation.

4) How is the potassium “20 mEq (K)” specified?

Potassium is specified in mEq, and the compounding site doses potassium chloride injection to reach the ordered 20 mEq/L (or per bag unit as written by the order set) and labels it accordingly.

5) What documentation should a supplier provide for these sterile admixtures?

Buyers typically require batch/lot traceability, sterile compounding compliance statements, and accurate final concentration labeling including potassium in mEq.

---

References

[1] U.S. Pharmacopeia. USP <797> Pharmaceutical Compounding - Sterile Preparations. U.S. Pharmacopeial Convention.